_id
69148240ccc777a4e85d93a0
Ticker
NKGN
Name
NKGen Biotech, Inc. Common Stock
Exchange
PINK
Address
3001 Daimler Street, Santa Ana, CA, United States, 92705
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://nkgenbiotech.com
Description
NKGen Biotech, Inc., a clinical-stage biotechnology company, develops and commercializes cell therapies for neurodegenerative and oncological diseases based on activated natural killer (NK) cells in the United States. The company develops SNK01, an autologous NK cell therapy candidate in Phase I/IIa trial for the treatment of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease; and SNK02, which consists of an allogenic NK cell therapy that has completed Phase 1 trial and a HER2-CAR NK cell therapy candidate in pre-clinical trial to treat refractory solid tumors. It has a strategic partnership with HekaBio K.K., a Japan-based healthcare platform, to develop, conduct clinical trials, obtain regulatory approvals, manufacture, and commercialize the company's autologous NK cell therapy product candidates for central nervous system and autoimmune conditions in Japan. The company also has a license agreement with NKMAX Co., Ltd. for the research and development of its NK cell program. NKGen Biotech, Inc. was founded in 2017 and is headquartered in Santa Ana, California.
Last Close
0.05
Volume
600
Current Price
0.06
Change
-9.090909090909086
Last Updated
2026-01-05T11:27:30.727Z
Image
data:image/webp;base64,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
Ipo Date
2021-07-13T00:00:00.000Z
Market Cap
6218837
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
652000
Cost Of Revenue
326000
Gross Profit
326000
Operating Expenses
5426000
Operating Income
-5100000
Interest Expense
4912000
Pretax Income
-29361000
Net Income
-29414000
Eps
-1.0202440788452283
Dividends Per Share
-
Shares Outstanding
124376734
Income Tax Expense
53000
EBITDA
-15266000
Operating Margin
-782.2085889570552
Total Other Income Expense Net
-24261000
Cash
-
Short Term Investments
-
Receivables
24000
Inventories
-
Total Current Assets
24000
Property Plant Equipment
-
Total Assets
24000
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
-
Equity
-
Bs_currency_symbol
-
Depreciation
331000
Change In Working Capital
-4045000
Cash From Operations
-6953000
Capital Expenditures
17000
Cash From Investing
-16000
Cash From Financing
6967000
Net Change In Cash
1738000
Cf_currency_symbol
-
PE
-
PB
-
ROE
-
ROA
-122558.33333333333
FCF
-6970000
Fcf Percent
-10.690184049079754
Piotroski FScore
1
Health Score
27
Deep Value Investing Score
0.5
Defensive Investing Score
3
Dividend Investing Score
1.5
Economic Moat Investing Score
2.3
Garp Investing Score
0
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
0
Quality Investing Score
0.5
Value Investing Score
0.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
652000
Quarters > 0 > income Statement > cost Of Revenue
326000
Quarters > 0 > income Statement > gross Profit
326000
Quarters > 0 > income Statement > operating Expenses
5426000
Quarters > 0 > income Statement > operating Income
-5100000
Quarters > 0 > income Statement > interest Expense
4912000
Quarters > 0 > income Statement > pretax Income
-29361000
Quarters > 0 > income Statement > net Income
-29414000
Quarters > 0 > income Statement > eps
-1.0202440788452283
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
28830356
Quarters > 0 > income Statement > income Tax Expense
53000
Quarters > 0 > income Statement > EBITDA
-15266000
Quarters > 0 > income Statement > operating Margin
-782.2085889570552
Quarters > 0 > income Statement > total Other Income Expense Net
-24261000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
-
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
24000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
24000
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
24000
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
-
Quarters > 0 > balance Sheet > equity
-
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-29414000
Quarters > 0 > cash Flow > depreciation
331000
Quarters > 0 > cash Flow > change In Working Capital
-4045000
Quarters > 0 > cash Flow > cash From Operations
-6953000
Quarters > 0 > cash Flow > capital Expenditures
17000
Quarters > 0 > cash Flow > cash From Investing
-16000
Quarters > 0 > cash Flow > cash From Financing
6967000
Quarters > 0 > cash Flow > net Change In Cash
1738000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-1.0202440788452283
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
-
Quarters > 0 > ratios > ROA
-122558.33333333333
Quarters > 0 > ratios > FCF
-6970000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-10.690184049079754
Quarters > 0 > health Score
27
Quarters > 1 > quarter
2024-09-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
6788000
Quarters > 1 > income Statement > operating Income
-6788000
Quarters > 1 > income Statement > interest Expense
472000
Quarters > 1 > income Statement > pretax Income
6598000
Quarters > 1 > income Statement > net Income
6598000
Quarters > 1 > income Statement > eps
0.27299734744059606
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
24168733
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
7402000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
13386000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
8000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
24000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
911000
Quarters > 1 > balance Sheet > property Plant Equipment
13991000
Quarters > 1 > balance Sheet > total Assets
14995000
Quarters > 1 > balance Sheet > payables
13451000
Quarters > 1 > balance Sheet > short Term Debt
19854000
Quarters > 1 > balance Sheet > long Term Debt
10604000
Quarters > 1 > balance Sheet > total Liabilities
62045000
Quarters > 1 > balance Sheet > equity
-47050000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
6598000
Quarters > 1 > cash Flow > depreciation
332000
Quarters > 1 > cash Flow > change In Working Capital
1647000
Quarters > 1 > cash Flow > cash From Operations
-3895000
Quarters > 1 > cash Flow > capital Expenditures
17000
Quarters > 1 > cash Flow > cash From Investing
-17000
Quarters > 1 > cash Flow > cash From Financing
3820000
Quarters > 1 > cash Flow > net Change In Cash
-92000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
0.27299734744059606
Quarters > 1 > ratios > PB
-0.03082091349628055
Quarters > 1 > ratios > ROE
-14.023379383634433
Quarters > 1 > ratios > ROA
44.00133377792598
Quarters > 1 > ratios > FCF
-3912000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
47
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
7457000
Quarters > 2 > income Statement > operating Income
-7457000
Quarters > 2 > income Statement > interest Expense
647000
Quarters > 2 > income Statement > pretax Income
-16088000
Quarters > 2 > income Statement > net Income
-16088000
Quarters > 2 > income Statement > eps
-0.665653429164036
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
24168733
Quarters > 2 > income Statement > income Tax Expense
647000
Quarters > 2 > income Statement > EBITDA
-15115000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-8631000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
79000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
23000
Quarters > 2 > balance Sheet > inventories
1123000
Quarters > 2 > balance Sheet > total Current Assets
1249000
Quarters > 2 > balance Sheet > property Plant Equipment
14306000
Quarters > 2 > balance Sheet > total Assets
15648000
Quarters > 2 > balance Sheet > payables
12694000
Quarters > 2 > balance Sheet > short Term Debt
17429000
Quarters > 2 > balance Sheet > long Term Debt
10372000
Quarters > 2 > balance Sheet > total Liabilities
85365000
Quarters > 2 > balance Sheet > equity
-69717000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-16088000
Quarters > 2 > cash Flow > depreciation
326000
Quarters > 2 > cash Flow > change In Working Capital
123000
Quarters > 2 > cash Flow > cash From Operations
-5999000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-15000
Quarters > 2 > cash Flow > cash From Financing
6059000
Quarters > 2 > cash Flow > net Change In Cash
45000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.665653429164036
Quarters > 2 > ratios > PB
-0.020800148887645767
Quarters > 2 > ratios > ROE
23.076150723639856
Quarters > 2 > ratios > ROA
-102.8118609406953
Quarters > 2 > ratios > FCF
-5999000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
39
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
326000
Quarters > 3 > income Statement > gross Profit
-326000
Quarters > 3 > income Statement > operating Expenses
7295000
Quarters > 3 > income Statement > operating Income
-7621000
Quarters > 3 > income Statement > interest Expense
1069000
Quarters > 3 > income Statement > pretax Income
-5382000
Quarters > 3 > income Statement > net Income
-5382000
Quarters > 3 > income Statement > eps
-0.24535369978745586
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
21935679
Quarters > 3 > income Statement > income Tax Expense
282724
Quarters > 3 > income Statement > EBITDA
-3987000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
2239000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
34000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
26000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
1607000
Quarters > 3 > balance Sheet > property Plant Equipment
14618000
Quarters > 3 > balance Sheet > total Assets
16316000
Quarters > 3 > balance Sheet > payables
12835000
Quarters > 3 > balance Sheet > short Term Debt
11719000
Quarters > 3 > balance Sheet > long Term Debt
10147000
Quarters > 3 > balance Sheet > total Liabilities
71371000
Quarters > 3 > balance Sheet > equity
-55055000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-5382000
Quarters > 3 > cash Flow > depreciation
326000
Quarters > 3 > cash Flow > change In Working Capital
2275000
Quarters > 3 > cash Flow > cash From Operations
-4034000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
35000
Quarters > 3 > cash Flow > cash From Financing
4007000
Quarters > 3 > cash Flow > net Change In Cash
8000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.24535369978745586
Quarters > 3 > ratios > PB
-0.023905925710652982
Quarters > 3 > ratios > ROE
9.775678866587958
Quarters > 3 > ratios > ROA
-32.98602598676146
Quarters > 3 > ratios > FCF
-4034000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2025-12-31
Annuals > 0 > income Statement > revenue
-
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
26966000
Annuals > 0 > income Statement > operating Income
-26966000
Annuals > 0 > income Statement > interest Expense
2724000
Annuals > 0 > income Statement > pretax Income
-44233000
Annuals > 0 > income Statement > net Income
-44286000
Annuals > 0 > income Statement > eps
-1.5360892525919556
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
28830356
Annuals > 0 > income Statement > income Tax Expense
53000
Annuals > 0 > income Statement > EBITDA
-26966000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-17267000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
-
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
24000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
24000
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
24000
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
-
Annuals > 0 > balance Sheet > equity
-
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-44286000
Annuals > 0 > cash Flow > depreciation
1315000
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-20881000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-13000
Annuals > 0 > cash Flow > cash From Financing
20853000
Annuals > 0 > cash Flow > net Change In Cash
1699000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-1.5360892525919556
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
-
Annuals > 0 > ratios > ROA
-184525
Annuals > 0 > ratios > FCF
-20881000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
1203000
Annuals > 1 > income Statement > gross Profit
-1203000
Annuals > 1 > income Statement > operating Expenses
28543000
Annuals > 1 > income Statement > operating Income
-29746000
Annuals > 1 > income Statement > interest Expense
745000
Annuals > 1 > income Statement > pretax Income
-82947000
Annuals > 1 > income Statement > net Income
-82954000
Annuals > 1 > income Statement > eps
-5.377227892977647
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
15426908
Annuals > 1 > income Statement > income Tax Expense
7000
Annuals > 1 > income Statement > EBITDA
-80999000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-53201000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
26000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
26000
Annuals > 1 > balance Sheet > inventories
-250000
Annuals > 1 > balance Sheet > total Current Assets
1930000
Annuals > 1 > balance Sheet > property Plant Equipment
14459000
Annuals > 1 > balance Sheet > total Assets
16481000
Annuals > 1 > balance Sheet > payables
11040000
Annuals > 1 > balance Sheet > short Term Debt
9991000
Annuals > 1 > balance Sheet > long Term Debt
9930000
Annuals > 1 > balance Sheet > total Liabilities
75174000
Annuals > 1 > balance Sheet > equity
-58693000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-82954000
Annuals > 1 > cash Flow > depreciation
1203000
Annuals > 1 > cash Flow > change In Working Capital
2226000
Annuals > 1 > cash Flow > cash From Operations
-21948000
Annuals > 1 > cash Flow > capital Expenditures
48000
Annuals > 1 > cash Flow > cash From Investing
-48000
Annuals > 1 > cash Flow > cash From Financing
22155000
Annuals > 1 > cash Flow > net Change In Cash
159000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-5.377227892977647
Annuals > 1 > ratios > PB
-0.013142033973386947
Annuals > 1 > ratios > ROE
141.3354233043123
Annuals > 1 > ratios > ROA
-503.3311085492385
Annuals > 1 > ratios > FCF
-21996000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
77000
Annuals > 2 > income Statement > cost Of Revenue
18000
Annuals > 2 > income Statement > gross Profit
59000
Annuals > 2 > income Statement > operating Expenses
24405000
Annuals > 2 > income Statement > operating Income
-24346000
Annuals > 2 > income Statement > interest Expense
2306000
Annuals > 2 > income Statement > pretax Income
-26747000
Annuals > 2 > income Statement > net Income
-26754000
Annuals > 2 > income Statement > eps
-1.2471637094659558
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
21451875
Annuals > 2 > income Statement > income Tax Expense
7000
Annuals > 2 > income Statement > EBITDA
-23231000
Annuals > 2 > income Statement > operating Margin
-31618.18181818182
Annuals > 2 > income Statement > total Other Income Expense Net
-2401000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
117000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
96000
Annuals > 2 > balance Sheet > inventories
133000
Annuals > 2 > balance Sheet > total Current Assets
350000
Annuals > 2 > balance Sheet > property Plant Equipment
15883000
Annuals > 2 > balance Sheet > total Assets
16330000
Annuals > 2 > balance Sheet > payables
975000
Annuals > 2 > balance Sheet > short Term Debt
12034000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
14767000
Annuals > 2 > balance Sheet > equity
1563000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-26754000
Annuals > 2 > cash Flow > depreciation
1650000
Annuals > 2 > cash Flow > change In Working Capital
30000
Annuals > 2 > cash Flow > cash From Operations
-22557000
Annuals > 2 > cash Flow > capital Expenditures
163000
Annuals > 2 > cash Flow > cash From Investing
-163000
Annuals > 2 > cash Flow > cash From Financing
22486000
Annuals > 2 > cash Flow > net Change In Cash
-234000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-1.2471637094659558
Annuals > 2 > ratios > PB
0.6862404030710173
Annuals > 2 > ratios > ROE
-1711.708253358925
Annuals > 2 > ratios > ROA
-163.83343539497858
Annuals > 2 > ratios > FCF
-22720000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-295.06493506493507
Annuals > 2 > health Score
15
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
426000
Annuals > 3 > income Statement > cost Of Revenue
30000
Annuals > 3 > income Statement > gross Profit
396000
Annuals > 3 > income Statement > operating Expenses
22257000
Annuals > 3 > income Statement > operating Income
-21861000
Annuals > 3 > income Statement > interest Expense
1315000
Annuals > 3 > income Statement > pretax Income
-23260000
Annuals > 3 > income Statement > net Income
-23265000
Annuals > 3 > income Statement > eps
-1.0845205838650467
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
21451875
Annuals > 3 > income Statement > income Tax Expense
5000
Annuals > 3 > income Statement > EBITDA
-20701000
Annuals > 3 > income Statement > operating Margin
-5131.69014084507
Annuals > 3 > income Statement > total Other Income Expense Net
-1399000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
351000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
67000
Annuals > 3 > balance Sheet > inventories
172000
Annuals > 3 > balance Sheet > total Current Assets
612000
Annuals > 3 > balance Sheet > property Plant Equipment
17369000
Annuals > 3 > balance Sheet > total Assets
18070000
Annuals > 3 > balance Sheet > payables
1714000
Annuals > 3 > balance Sheet > short Term Debt
51611000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
56122000
Annuals > 3 > balance Sheet > equity
-38052000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-23265000
Annuals > 3 > cash Flow > depreciation
1244000
Annuals > 3 > cash Flow > change In Working Capital
932000
Annuals > 3 > cash Flow > cash From Operations
-19548000
Annuals > 3 > cash Flow > capital Expenditures
459000
Annuals > 3 > cash Flow > cash From Investing
-459000
Annuals > 3 > cash Flow > cash From Financing
20159000
Annuals > 3 > cash Flow > net Change In Cash
152000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-1.0845205838650467
Annuals > 3 > ratios > PB
-0.028187578839482814
Annuals > 3 > ratios > ROE
61.14001892147588
Annuals > 3 > ratios > ROA
-128.74930824571112
Annuals > 3 > ratios > FCF
-20007000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-46.96478873239437
Annuals > 3 > health Score
30
Valuation > metrics > PE
-1.0202440788452283
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROA
-122558.33333333333
Profitability > metrics > Net Margin
-45.11349693251534
Profitability > final Score
20
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-1.038273615635179
Risk > final Score
26
Risk > verdict
High
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
70
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
45
Prev Profitabilities > 1
55
Prev Profitabilities > 2
35
Prev Risks > 0
-28
Prev Risks > 1
-16
Prev Risks > 2
1
Prev Liquidities > 0
11
Prev Liquidities > 1
10
Prev Liquidities > 2
13
Updated At
2026-01-20T22:17:10.752Z
Earnings History > 0 > period
2024-12-31
Earnings History > 0 > report Date
2025-03-04
Earnings History > 0 > date
2024-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0.15
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0.15
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2024-09-30
Earnings History > 1 > report Date
2024-09-30
Earnings History > 1 > date
2024-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.1526
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-06-30
Earnings History > 2 > report Date
2024-09-12
Earnings History > 2 > date
2024-06-30
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.6657
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-03-31
Earnings History > 3 > report Date
2024-05-20
Earnings History > 3 > date
2024-03-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.2454
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2023-12-31
Earnings History > 4 > report Date
2023-12-31
Earnings History > 4 > date
2023-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-1.5353
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2023-09-30
Earnings History > 5 > report Date
2023-09-30
Earnings History > 5 > date
2023-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-2.4763
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2023-06-30
Earnings History > 6 > report Date
2023-06-30
Earnings History > 6 > date
2023-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.1088
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-03-31
Earnings History > 7 > report Date
2023-03-31
Earnings History > 7 > date
2023-03-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
0.0177
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2022-12-31
Earnings History > 8 > report Date
2023-03-31
Earnings History > 8 > date
2022-12-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.14
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.14
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2022-09-30
Earnings History > 9 > report Date
2022-11-14
Earnings History > 9 > date
2022-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
0.04
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
0.04
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2022-06-30
Earnings History > 10 > report Date
2022-08-15
Earnings History > 10 > date
2022-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
0.22
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
0.22
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-03-31
Earnings History > 11 > report Date
2022-05-16
Earnings History > 11 > date
2022-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0.09
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0.09
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2021-12-31
Earnings History > 12 > report Date
2022-03-31
Earnings History > 12 > date
2021-12-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.07
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.07
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2021-09-30
Earnings History > 13 > report Date
2021-11-15
Earnings History > 13 > date
2021-09-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
0.22
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
0.22
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2021-06-30
Earnings History > 14 > report Date
2021-08-16
Earnings History > 14 > date
2021-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.2
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.2
Earnings History > 14 > surprise Percent
-
NKGen Biotech, Inc., a clinical-stage biotechnology company, develops and commercializes cell therapies for neurodegenerative and oncological diseases based on activated natural killer (NK) cells in the United States. The company develops SNK01, an autologous NK cell therapy candidate in Phase I/IIa trial for the treatment of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease; and SNK02, which consists of an allogenic NK cell therapy that has completed Phase 1 trial and a HER2-CAR NK cell therapy candidate in pre-clinical trial to treat refractory solid tumors. It has a strategic partnership with HekaBio K.K., a Japan-based healthcare platform, to develop, conduct clinical trials, obtain regulatory approvals, manufacture, and commercialize the company's autologous NK cell therapy product candidates for central nervous system and autoimmune conditions in Japan. The company also has a license agreement with NKMAX Co., Ltd. for the research and development of its NK cell program. NKGen Biotech, Inc. was founded in 2017 and is headquartered in Santa Ana, California.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AFinancial Review: Alpha Cognition (OTC:ACOGF) vs. NKGen Biotech (NYSE:NKGN) Defense World
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of NKGen Biotech, Inc. Common Stock
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2024-12-31
EPS Actual
0.15
EPS Estimate
0
EPS Difference
0.15
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.